我的购物车

Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) (MALS verified)

用户评价
货号-规格
价格
Qty.
合计0件 产品金额0
0
加入购物车

产品详情

  • 抗体来源(Source)

    Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.

  • 克隆号(Clone)

    13B8

  • 亚型(Isotype)

    Human IgG1 | Human Kappa

  • 偶联(Conjugate)

    Unconjugated

  • 抗体类型(Antibody Type)

    Recombinant Monoclonal

  • 种属反应性(Reactivity)

    Human

  • 免疫原(Immunogen)

    Recombinant Human TNF-alpha derived from human HEK293 cells.

  • 特异性(Specificity)

    This product is a specific antibody that has a specific response to tnf-α in humans, Canine and Rhesus macaque.

  • 应用(Application)

    Application
    Recommended Usage
    ELISA
    0.1-12.5 ng/mL
  • 纯度(Purity)

    95% as determined by SDS-PAGE.

    95% as determined by SEC-MALS.

  • 纯化(Purification)

    Protein A purified / Protein G purified

  • 制剂(Formulation)

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储(Storage)

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

产品展示

  • 电泳(SDS-PAGE)

    TNF-alpha SDS-PAGE

    Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • SEC-MALS

    TNF-alpha SEC-MALS

    The purity of Monoclonal Anti-TNF-alpha Antibody, Human IgG1 (13B8) (Cat. No. TNA-AM493) is more than 95% and the molecular weight of this protein is around 135-160 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-ELISA

     TNF-alpha ELISA

    ImmobilizedHuman TNF-alpha Protein, His Tag (active trimer) (MALS verified) (Cat. No. TNA-H5228) at 2μg/mL (100μL/well) can bind Monoclonal Anti-TNF-alpha antibody, Human IgG1 (13B8) (Cat. No. TNA-AM493) with a linear range of 0.05-1.56 ng/mL (QC tested).

    Protocol
  • 活性(Bioactivity)-SPR

     TNF-alpha SPR

    Monoclonal Anti-TNF-alpha antibody, Human IgG1 (13B8) (Cat. No. TNA-AM493) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human TNF-alpha, His Tag (Cat. No. TNA-H5228) with an affinity constant of 0.133 nM as determined in a SPR assay (Biacore 8K) (Routly tested).

    Protocol
  • 活性(Bioactivity)-BLI

     TNF-alpha BLI

    Loaded Monoclonal Anti-TNF-alpha antibody, Human IgG1 (13B8) (Cat. No. TNA-AM493) on Protein A Biosensor, can bind Human TNF-alpha, His Tag (active trimer) (MALS verified) (Cat. No. TNA-H5228) with an affinity constant of 1.03 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol
  •  TNF-alpha BLI

    Loaded Monoclonal Anti-TNF-alpha antibody, Human IgG1 (13B8) (Cat. No. TNA-AM493) on Protein A Biosensor, can bind Human TNF-alpha, premium grade (MALS verified) (Cat. No. TNA-H4211) with an affinity constant of 2.97 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol
  •  TNF-alpha BLI

    Loaded Monoclonal Anti-TNF-alpha antibody, Human IgG1 (13B8) (Cat. No. TNA-AM493) on Protein A Biosensor, can bind Canine TNF-alpha, His Tag (Cat. No. TNA-C52H3) with an affinity constant of 2.24 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

用户评价
发表评论

背景介绍

Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimer's disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated.

前沿进展

 
药物研发进展
  • 英文全称:

    Tumor necrosis factor α

  • 中文全称:

    肿瘤坏死因子α

  • 种类:

  • 上市药物数量:

    64 详情

  • 临床药物数量:

    71 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价
  • 背景介绍